The PEth Results Communication Study
PERC
The Phosphatidylethanol (PEth) Results Communication (PERC) Study
2 other identifiers
interventional
80
1 country
1
Brief Summary
This is a randomized controlled trial (RCT) to test whether adding PEth (a blood test that shows recent alcohol use) to a standard alcohol counseling session in clinic helps people with HIV reduce their drinking. A total of 80 participants will be enrolled with unhealthy alcohol use: 40 will receive the standard MOH brief alcohol counseling plus discussion of their PEth results and 40 will receive the standard Uganda Ministry of Health (MOH) brief alcohol counseling alone. After 3 months, the study will look at whether participants found the intervention acceptable, appropriate, and feasible. The study also explore changes in alcohol use, motivation to reduce drinking, and experiences of stigma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 5, 2026
April 1, 2026
7 months
August 4, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acceptability of PEth-Boosted BI
Acceptability of the PEth-Boosted Brief Intervention will be assessed using the "Acceptability of Intervention Measure (AIM)", a 4-item scale with an overall score ranging from 1-5; higher scores indicate more acceptability.
3 months
Secondary Outcomes (3)
Changes in readiness for long-term alcohol reduction
3 months
Self-reported alcohol use and PEth
3 months
Alcohol-related stigma
3 months
Other Outcomes (2)
Feasibility of PEth-Boosted BI
3 months
Appropriateness of PEth-Boosted BI
3 months
Study Arms (2)
PEth Boosted BI
EXPERIMENTALParticipants in the PEth-Boosted BI arm will receive alcohol counseling (brief intervention, or BI) from a trained counselor who will be trained in the Uganda Ministry of Health's standard BI plus communication of PEth test results.
Standard BI
NO INTERVENTIONParticipants in the Standard BI arm will receive alcohol counseling (brief intervention, or BI) from a trained counselor who will be trained in the Uganda Ministry of Health's standard BI.
Interventions
Participants in the intervention arm of the study will receive an alcohol BI delivered by study staff boosted by PEth results communication per study-developed protocols.
Eligibility Criteria
You may qualify if:
- years and older;
- Resident in the study catchment area (\<60 km or \<2 hours travel);
- Fluent in Runyankole or English;
- Ability to give informed consent;
- Unhealthy alcohol use (AUDIT-C ≥3 for women, ≥4 for men, OR PEth≥20); ng/mL at a previous study visit or PERC screening);
- Having participated in a previous study, except for TRAC and PERC studies.
You may not qualify if:
- Having already participated in Aim 1 of this study;
- Having participated in the TRAC Study;
- Not fluent in English or Runyankole;
- Gross inebriation, cognitive impairment, or inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mbarara Univeristy of Science and Technology
Mbarara, 99999, Uganda
Related Publications (1)
Haroz EE, Bolton P, Nguyen AJ, Lee C, Bogdanov S, Bass J, Singh NS, Doty B, Murray L. Measuring implementation in global mental health: validation of a pragmatic implementation science measure in eastern Ukraine using an experimental vignette design. BMC Health Serv Res. 2019 Apr 29;19(1):262. doi: 10.1186/s12913-019-4097-y.
PMID: 31036002BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Judith A Hahn, PhD, MA
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2025
First Posted
March 2, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data for this RCT will be made available according to the guidelines of the NIAAADA. All scientific data generated from this project will be made available no later than the time of publication or the end of the funding period (May 30, 2027), whichever comes first. The duration of preservation and sharing of the data will be for the lifetime of the NIAAADA.
- Access Criteria
- The PERC Study data will be shared in a way that minimizes barriers to access and use and in accordance with NIAAADA guidelines. There are no anticipated factors or limitations that will affect the access, distribution or reuse of the scientific data. Data will be accessible upon approval according to the guidelines for data use of the NIAAADA. Study data will be findable and identifiable by the NDA search functions.
We will share de-identified data from the PERC study randomized controlled trial (RCT) described in Aim 2 to promote transparency and enable other researchers to build upon our findings. The quantitative data from this RCT will be shared with the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA) a data repository housed within the NIMH Data Archive (NDA). Data from 80 participants will consist of self-reported survey data (e.g., demographics, alcohol and drug use), alcohol biomarker results (phosphatidylethanol \[PEth\]) derived from dried blood spot (DBS) samples, and study-specific data including; HIV viral load and self-reported antiretroviral therapy (ART) adherence (single-item measure), health care worker-enacted substance use-related stigma and anticipated stigma, internalized substance use-related stigma, and internalized HIV stigma. Data will be stored in Stata format and made available in Excel for ease of access.